{"nct_id":"NCT00982657","title":"A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma","status":"TERMINATED","status_verified_date":"2015-10","start_date":"2009-09","start_date_type":null,"primary_completion_date":"2014-03","primary_completion_date_type":"ACTUAL","completion_date":"2014-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}